KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Enterprise Value (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.77%
Dec 31, 2025 35.33%
Sep 30, 2025 -21.44%
Jun 30, 2025 -15.58%
Mar 31, 2025 -8.49%
Dec 31, 2024 -34.47%
Sep 30, 2024 -21.78%
Jun 30, 2024 31.35%
Mar 31, 2024 21.37%
Dec 31, 2023 -60.41%
Sep 30, 2023 12.13%
Jun 30, 2023 5.80%
Mar 31, 2023 -0.12%
Dec 31, 2022 -2.59%
Sep 30, 2022 31.92%
Jun 30, 2022 11.65%
Mar 31, 2022 11.85%
Dec 31, 2021 -8.43%
Sep 30, 2021 -20.83%
Jun 30, 2021 -0.33%
Mar 31, 2021 18.45%
Dec 31, 2020 25.20%
Sep 30, 2020 2.36%
Jun 30, 2020 -18.27%
Mar 31, 2020 -19.37%
Dec 31, 2019 52.85%
Sep 30, 2019 -10.87%
Jun 30, 2019 -237.62%
Mar 31, 2019 -0.02%
Dec 31, 2018 -28.91%
Sep 30, 2018 -12.49%
Jun 30, 2018 10.26%
Mar 31, 2018 37.98%
Dec 31, 2017 -53.54%
Sep 30, 2017 -9.53%
Jun 30, 2017 -6.56%
Mar 31, 2017 3.07%
Dec 31, 2016 -14.61%
Sep 30, 2016 -20.06%
Jun 30, 2016 -8.43%
Mar 31, 2016 -0.73%
Dec 31, 2015 21.21%
Sep 30, 2015 1.68%
Jun 30, 2015 28.89%
Mar 31, 2015 -2.19%
Dec 31, 2014 -1.97%
Sep 30, 2014 -0.56%
Jun 30, 2014 -1.74%
Mar 31, 2014 -57.57%
Dec 31, 2013 -62.51%
Sep 30, 2013 2.25%
Jun 30, 2013 -12.19%
Mar 31, 2013 11.41%
Dec 31, 2012 3.96%
Sep 30, 2012 44.96%
Jun 30, 2012 -3.96%
Mar 31, 2012 41.96%
Dec 31, 2011 -5.92%
Sep 30, 2011 -5.72%
Jun 30, 2011 -14.34%
Mar 31, 2011 6.59%
Dec 31, 2010 35.28%
Sep 30, 2010 -18.73%
Jun 30, 2010 -19.52%
Mar 31, 2010 6.31%
Dec 31, 2009 2.94%
Sep 30, 2009 7.81%
Jun 30, 2009 -1,001.15%